[1] Morgentaler A, Miner MM, Caliber M, et al. Testosterone therapy and cardiovascular risk:advances and controversies[J]. Mayo Clin Proc, 2015, 90(2):224-251.
[2] Malkin CJ, Pugh PJ, West JN, et al. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial [J]. Eur Heart J, 2006, 27(1): 57-64.
[3] Chimenti C, Kajstura J, Torella D, et al. Senescence and death of primitive cells and myocyteslead to premature cardiac aging and heart failure[J]. Circ Res, 2003,93(7):604-613.
[4] Wong LS, van der Harst P, de Boer RA, et al. Aging, telomeres and heart failure[J]. Heart Fail Rev,2010,15(5): 479-486.
[5] Zhang L, Wu SZ, Ruan YJ, et al. Testosterone therapy delays cardiomyocyte aging via androgen receptor-independent pathway [J]. Braz J Med Bio Res, 2011, 44(11):1118-1124.
[6] Samaras N, Papadopoulou MA, Samaras D, et al. Off-label use of hormones as an antiagingstrategy: a review[J]. Clin Interv Aging, 2014, 23(9): 1175-1186.
[7] Pongkan W, Chattipakorn SC, Chattipakorn N. Role of testosterone replacement in cardiac ischemia-reperfusion injury[J]. J Cardiovasc Pharmacol Ther, 2016, 21(1):27-43.
[8] 边 瓯,马 宁,乔 锐,等.高龄男性2型心肾综合征患者血清睾酮水平的研究[J].国际心血管病杂志,2014,41(5):350-352.
[9] Frye CA, Edinger K, Sumida K. Androgen administration to aged male mice increases anti-anxiety behavior and enhances cognitive performance[J]. Neuropsychopharmacology, 2008, 33(5): 1049-1061.
[10] Ota H, Akishita M, Akiyoshi T, et al. Testosterone deficiency accelerates neuronal and vascular aging of SAMP8 mice: protective role of eNOS and SIRT1 [J]. PLoS One, 2012, 7(1): e29598.
[11] Pongkan W, Chattipakorn SC, Chattipakorn N. Chronic testosterone replacement exerts cardioprotection against cardiac ischemia- reperfusion injury by attenuating mitochondrial dysfunction in testosterone- deprived rats[J]. PLoS One, 2015, 10(3):e0122503.
[12] Pugh PJ, Jones RD, West JN, et al. Testosterone treatment for men with chronic heart failure[J].Heart, 2004, 90(4):446-447.
[13] Vinciguerra M, Santini MP, Martinez C, et al. mIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart [J]. Aging Cell, 2012,11(1):139-149.
[14] Wang F, Yang J, Sun J, et al. Testosterone replacement attenuates mitochondrial damage in a rat model of myocardial infarction [J].Endocrinol, 2015, 225(2): 101-111.
[15] Eleawa SM, Sakr HF, Hussein AM, et al. Effect of testosterone replacement therapy on cardiac performance and oxidative stress in orchidectomizedrats[J]. Acta Physiol(Oxf), 2013,209(2):136-147.
[16] Alcendor RR, Gao S, Zhai P, et al. Sirt1 regulates aging and resistance to oxidative stress in the heart [J]. Circ Res, 2007, 100(10):1512-1521.
[17] Kataoka T, Hotta Y, Maeda Y, et al. Assessment of androgen replacement therapy for erectilefunction in rats with type 2 diabetes mellitus by examining nitric oxide-related and inflammatory factor[J]. J Sex Med, 2014, 11(4):920-929.